| Sources | Names Used |
|---|---|
| CTRPv2 | triazolothiadiazine |
| PharmacoGx | triazolothiadiazine |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD109 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | CCNJ | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | KIF2C | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-06 |
| mRNA | SSFA2 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | HADH | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | TIMP2 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | SRP9 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-06 |
| mRNA | PHF10 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | INTS10 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | C1orf174 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-06 |
